Some analysts project a 12-month price target averaging , implying over 20% upside.

AI responses may include mistakes. For financial advice, consult a professional. Learn more Is CVS Health the Ultimate Value Stock to Buy Right Now?

: Ongoing antitrust scrutiny of pharmacy benefit managers (PBMs) and potential changes to Medicare Advantage rates remain key risks for the 2027 fiscal year.

The company has increased its dividend by 33% since 2022 and currently pays annually.

Management projects 2026 adjusted EPS between .

CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights

: While 2026 rates were better than feared, fluctuating Medicare reimbursement and higher medical utilization costs can squeeze insurance margins.

Just Before you Leave!

Are you trying to launch scalable custom apps at speed? Let us give you the headstart you need.